Investing
Investing Cash Flow
Pfizer Investing Cash Flow increased by 112.8% to $785.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 76.0%, from $3.27B to $785.00M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -60.9% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Typically negative for growing companies as they reinvest cash; a positive value suggests the company is liquidating assets faster than it is buying them.
Detailed definition
The aggregate sum of all cash inflows and outflows related to a company's long-term investments and capital assets. It s...
Peer comparison
Mature companies with high cash flow often show large negative values here as they recycle profits into new growth or financial instruments.
Metric ID:
net_cash_from_investingHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.14B | -$10.08B | -$2.59B | $567.00M | -$11.31B | -$627.00M | -$4.41B | $3.32B | -$25.49B | $888.00M | -$11.00B | $1.73B | $4.60B | -$2.06B | $3.27B | $3.95B | -$2.43B | -$6.15B | $785.00M |
| QoQ Change | — | -23.8% | +74.3% | +121.9% | <-999% | +94.5% | -603.3% | +175.2% | -868.8% | +103.5% | <-999% | +115.8% | +165.6% | -144.7% | +259.2% | +20.7% | -161.5% | -152.9% | +112.8% |
| YoY Change | — | — | — | — | -39.0% | +93.8% | -70.5% | +484.7% | -125.3% | +241.6% | -149.3% | -47.8% | +118.0% | -331.6% | +89.0% | -14.1% | -18.1% | — | -76.0% |
Range-$25.49B – $4.60B
CAGR-40.5%
Avg YoY Growth+11.1%
Median YoY Growth-28.6%
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Pfizer's investing cash flow?
- Pfizer (PFE) reported investing cash flow of $785.00M in Q1 2026.
- How has Pfizer's investing cash flow changed year-over-year?
- Pfizer's investing cash flow decreased by 76.0% year-over-year, from $3.27B to $785.00M.
- What is the long-term trend for Pfizer's investing cash flow?
- Over 3 years (2021 to 2025), Pfizer's investing cash flow has grown at a -60.9% compound annual growth rate (CAGR), from -$22.55B to -$1.35B.
- What does investing cash flow mean?
- The total net change in cash resulting from buying and selling long-term assets and investments.